If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 2001-2005 Ph.D., Biological Sciences-Genetics & Complex Diseases, Graduate School of Arts & Sciences, Harvard University
  • 1986-1993 M.D., School of Medicine, Taipei Medical University

Experience

Postdoctoral Training

  • 2005-2007 Postdoctoral Fellow, Institute for Medicine and Engineering, University of Pennsylvania, PA, USA
  • 2005-2007 Postdoctoral Fellow, Department of Surgery and Center for Bioengineering & Tissue Regeneration, University of California, San Francisco, CA, USA
  • 1998-2000 Clinical Fellow, Division of Critical Care, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
  • 1996-1998 Chief Resident, Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
  • 1993-1996 Resident, Department of Medicine, Taipei Veterans General Hospital, Taiwan

Academic Appointments

  • 2017- Joint Associate Investigator, National Institute of Cancer Research, National Health Research Institutes, Taiwan
  • 2014- Associate Professor of Medicine, Graduate Institute of Clinical Research, School of Medicine, TMU
  • 2014-2017 Associate Investigator, National Institute of Cancer Research, National Health Research Institutes
  • 2008-2013 Assistant Investigator, National Institute of Cancer Research, National Health Research Institutes

Clinical Appointments

  • 2019- Director, Clinical Research Center, Wan Fang Hospital, Taipei Medical University
  • 2019- Deputy Director, Integrative Therapy Center for Gastroenterological Cancers, Wan Fan Hospital, Taipei Medical University
  • 2018- Attending Physician, Division of Gastroenterology, Department of Medicine, Wan Fang Hospital, Taipei Medical University
  • 2008-2017 Attending Physician, National Institute of Cancer Research, National Health Research Institutes
  • 2009-2017 Attending Physician, Division of Hematology-oncology, Department of Medicine, National Cheng-Kung University Hospital, Tainan, Taiwan
  • 2000-2004 Attending Physician, Department of Medicine, Taipei Veterans General Hospital

Awards

  • 2019 Research Dissertation Award - Clinical Research Award, Taipei Medical University
  • 2018 Outstanding Research Award (Life Science), Ministry of Science and Technology (MOST), Taiwan
  • 2018 The 5th Kobayashi's Foundation Award, Kobayashi Foundation for Cancer Research, Japan
  • 2017 Ta-Cheng Tung's Basic Cancer Research Award, Taiwan Oncology Society
  • 2017 The Breast Journal Award, Wiley-Blackwell, USA
  • 2016 Research Prize, NCKUH, Taiwan
  • 2014 Young Scientist Research Achievement Award, National Health Research Institutes, Taiwan
  • 2014 Research Prize, NCKUH, Taiwan
  • 2012 Merit Award, Asian Clinical Oncology Society (ACOS)
  • 2005 Ruth L. Kirschstein National Research Service Award, National Institutes of Health (NIH), USA
  • 2004 Harvard Presidential Scholar, Harvard University, Cambridge, MA, USA
  • 2004 Glenn/AFAR Scholar, American Federation for Aging Research, USA
  • 2001-2003 Government Scholar, Ministry of Education (MOE), Taiwan
  • 2001 Scholarship of the Ivy Association for Cultural and Educational Exchange, Taiwan
  • 1999 Research Prize, TVGH, Taiwan

Research Interests

  • Cell and Molecular Biology
  • Cancer Biology
  • Cancer Stem Cells
  • Cancer Molecular Medicine
  • Pancreatic Cancer
  • Breast Cancer
  • Cancer Treatment Resistance

Other

Medical Licensure

  • 2011 ECFMG Certificate, USA
  • 1999 Board Certified, Gastroenterology, Taiwan
  • 1999 Board Certified, Digestive Endoscopy, Taiwan
  • 1996 Board Certified, Internal Medicine, Taiwan

Memberships

  • 2015- Taiwan Oncology Society
  • 2013- American Association for Cancer Research
  • 2006- The American Society for Cell Biology
  • 2006- Harvard Alumni Association
  • 1999- The Digestive Endoscopy Society of Taiwan
  • 1999- The Gastroenterology Society of Taiwan
  • 1996- Taiwan Society of Internal Medicine

Fingerprint Dive into the research topics where Kelvin Kun-Chih Tsai is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Neoplasms Medicine & Life Sciences
Leukocytes Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Fibroblasts Medicine & Life Sciences
Neoplastic Stem Cells Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Apoptosis Medicine & Life Sciences
Catenins Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2016 2020

ASPM與Wnt訊息傳導在肝癌幹原性與惡化以及相關奈米基因治療之開發(3/3)

Tsai, K. K.

8/1/197/1/20

Project: A - Government Institutionb - Ministry of Science and Technology

ASPM-PAR-PCP訊息軸於侵犯性癌幹細胞造成癌轉移的角色與其標靶治療(1/3)

Tsai, K. K.

8/1/197/1/20

Project: A - Government Institutionb - Ministry of Science and Technology

蔡坤志-107研究計畫績效獎

Tsai, K. K.

8/1/187/31/20

Project: B - Project of TMUh - Other (Funded by TMU)

108年度研究型主治醫師研究計畫-蔡坤志醫師

Tsai, K. K.

1/1/1912/1/19

Project: A - Government Institutiond - Ministry of Education

Research Output 1998 2020

  • 1522 Citations
  • 20 h-Index
  • 33 Article
  • 4 Review article
  • 2 Comment/debate

A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 study

Chiang, N. J., Tsai, K. K., Hsiao, C. F., Yang, S. H., Hsiao, H. H., Shen, W. C., Hsu, C., Lin, Y. L., Chen, J. S., Shan, Y. S. & Chen, L. T., Jan 2020, In : European Journal of Cancer. 124, p. 123-130 8 p.

Research output: Contribution to journalArticle

oxaliplatin
gemcitabine
Leucovorin
Adenocarcinoma
irinotecan
5 Citations (Scopus)

ASPM promotes prostate cancer stemness and progression by augmenting Wnt−Dvl-3−β-catenin signaling

Pai, V. C., Hsu, C. C., Chan, T. S., Liao, W. Y., Chuu, C. P., Chen, W-Y., Li, C. R., Lin, C. Y., Huang, S. P., Chen, L. T. & Tsai, K. K., Feb 21 2019, In : Oncogene. 38, 8, p. 1340-1353 14 p.

Research output: Contribution to journalArticle

Catenins
Microcephaly
Prostatic Neoplasms
Neoplastic Stem Cells
Neoplasms
2 Citations (Scopus)

Correction: ASPM promotes prostate cancer stemness and progression by augmenting Wnt−Dvl-3−β-catenin signaling (Oncogene, (2019), 38, 8, (1340-1353), 10.1038/s41388-018-0497-4)

Pai, V. C., Hsu, C. C., Chan, T. S., Liao, W. Y., Chuu, C. P., Chen, W-Y., Li, C. R., Lin, C. Y., Huang, S. P., Chen, L. T. & Tsai, K. K., Feb 21 2019, In : Oncogene. 38, 8, p. 1354 1 p.

Research output: Contribution to journalComment/debate

Catenins
Oncogenes
Prostatic Neoplasms

Histone demethylase KDM4C stimulates the proliferation of prostate cancer cells via activation of AKT and c-Myc

Lin, C. Y., Wang, B. J., Chen, B. C., Tseng, J. C., Jiang, S. S., Tsai, K. K., Shen, Y. Y., Yuh, C. H., Sie, Z. L., Wang, W. C., Kung, H. J. & Chuu, C. P., Nov 2019, In : Cancers. 11, 11, 1785.

Research output: Contribution to journalArticle

Open Access
Histone Demethylases
Prostatic Neoplasms
Prostate
Androgen Receptors
Cell Proliferation
Open Access
Neoplastic Stem Cells
Mesenchymal Stromal Cells
Fibroblasts
Carcinoma
Neoplasms